Zimmer Biomet Holdings (ZBH) Equity Average (2009 - 2026)

Zimmer Biomet Holdings has reported Equity Average for 18 years, with the latest figure at $12.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 2.04% year-over-year to $12.7 billion; the trailing twelve-month figure through Mar 2026 stood at $12.7 billion (up 2.04% YoY), and the FY2025 full-year result was $12.6 billion, up 0.87% from the prior year.
• Equity Average for Q1 2026 stood at $12.7 billion, roughly flat from $12.7 billion in the prior quarter.
• The five-year high for Equity Average was $12.7 billion in Q4 2025, with the low at $12.1 billion in Q2 2022.
• Average Equity Average over 5 years is $12.4 billion, with a median of $12.4 billion recorded in 2023.
• Year-over-year, Equity Average decreased 4.34% in 2022 and rose 3.76% in 2024.
• Tracing ZBH's Equity Average over 5 years: stood at $12.1 billion in 2022, then grew by 3.0% to $12.5 billion in 2023, then dropped by 0.59% to $12.4 billion in 2024, then grew by 2.43% to $12.7 billion in 2025, then declined by 0.29% to $12.7 billion in 2026.
• The last three Equity Average figures came in at $12.7 billion (Q1 2026), $12.7 billion (Q4 2025), and $12.6 billion (Q3 2025), per Business Quant data.

Peer Comparison